It is very common, men with advanced prostate cancer find that they are subject to confusion and memory loss; they experience a general dumbing down of their brain facilities. The most common culprits causing this are hormone therapy (ADT) and chemotherapy treatments. At this time we don’t have any great magic bullets to treat this [...]
The Early Access Committee Announces an Additional Site for Radium-223 Chloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases We have been able to get Bayer to open another early access site for Alpharedin. This additional site is in Boston, Ma. In addition to this new site there are still three other sites. [...]
The big news from yesterday is that the Food and Drug Administration (FDA) has approved a MRI-guided, focused ultrasound therapy for the treatment of bone pain associated with metastatic advanced prostate cancer. In a media release written by InSight, an Israeli company states that its ExAblate® MRI-guided, focused ultrasound technology is indicated to treat pain [...]
A recently published article in Urology Times claims that salvage high-intensity focused ultrasound (HIFU) appears to be an effective treatment option for locally recurrent prostate cancer after primary external beam radiation therapy (EBRT) failure. The study, which this article reported on, used data from analyses of 6-year oncologic outcomes show. When the researchers did a [...]
I try not to get political in this blog, but current politics are directly involved in our healthcare and that is what I write about in this blog. I write this because all of my work is dedicated to improving the quality of life and for saving lives. Candidate Mitt Romney has been very clear; [...]
Data presented at the European Society for Medical Oncology annual congress in Vienna, Austria linked the delay of pain progression the functional decline of men with the newly approved drug Zytiga. The data was derived from an additional anaylisis of the phase 3 trial (COU-AA-302) that led to the FDA approval of Zytiga. The FDA [...]
There was just a new site opened for the early/expanded access program for Alpharedin (Radium-235). The new site is at Stanford University, California. This makes a total of four sites, but most of them have not been adequately supported by the drug company, Bayer. Hopefully, this site will be better supported, but if it too [...]
It is the general consensus that prostate cancer when still confined to the prostate gland is gland curable, but when it has left the prostate gland and becoming metastatic it is no longer curable. But evidence now says there might be an intermediate stage where the cancer has spread outside the prostate gland but is [...]
Powdered turmeric is a common ingredient of Indian food and a substance that has been used for centuries to treat osteoarthritis and other illnesses. In March 2012 researchers from Michigan State University found that curcumin may be beneficial for people with Parkinson's disease as well as head and neck cancers. It is now thought that [...]
Fall is quickly approaching, along with the colors it also brings the influenza. For most people influenza is a bother, but for cancer survivors it brings many unique concerns not shared with the general population. It brings serious illness, hospitalizations and possibly death! During an influenza epidemic, between 21% and 33% of cancer survivors who [...]
